Click here to see this online
 
 
 

April 13, 2017

 
 
 

KnowEnG Center Annual NIH Site Visit and External Advisory Council Meeting, April 27-28

The KnowEng Annual NIH Site Visit and External Advisory Council Meeting will be held April 27-28, 2017 at the Carle R. Woese Institute for Genomic Biology. Details about the program and registration information can be found here.

 
 
 
 Faculty Seminar Poster
 

Cancer Community at Illinois Faculty Seminar, May 2

The Cancer Community at Illinois Faculty Seminar Series will hold the final session of the semester on Thursday, May 4.

Thursday, May 4 | 3:00 p.m. - 4:30 p.m.
Health Care Engineering Systems Center (HCESC), Room 1232
(HCESC is in the lower level of the North Campus Parking Deck Building at 1206 W Clark Street, Urbana, IL)

The May speakers are:

  • John Erdman (Food Science and Human Nutrition)
  • Barbara Fiese (Family Resiliency Center)
  • William Helferich (Nutritional Sciences)
  • Brendan Harley (Chemical and Biomolecular Engineering)

Advance registration is requested at go.illinois.edu/CancerLectureSeries.

 
 
 

WORKSHOPS AND SEMINARS

 
 
 
 CSTAR Reception Flier
 

CSTAR Reception: Registration Deadline Tomorrow

The CSTAR program will be holding a reception April 19, 2017. This is a great opportunity for faculty, students, and physicians to learn more about the exciting research happening in the CSTAR program. (Click the image at right to see more detail about the event program.)

Carle and Illinois Reception
April 19, 2017
4:00 - 6:00 p.m.

Mills Breast Cancer Center
Carle Houseworth Conference Center (2nd floor)

Please RSVP by Noon on April 14, 2017.

 
 
 

HHMI Investigator Panel, April 19

The Office of the Vice Chancellor for Research is sponsoring a HHMI Investigator Panel on Wednesday, April 19, 2017. The Howard Hughes Medical Institute (HHMI) will appoint up to 20 new biomedical researchers for up to 7 years through a national open competition. (It is not a limited submission.) The competition is open to basic researchers and physician-scientists who bring innovative approaches to the study of biological problems in biomedical disciplines, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering and computational biology.

HHMI Panel
April 19, 2017, Wednesday 10:00 AM
Room 350 B at ERML – Edward R. Madigan Labs

Panelists:

  • Martin Burke, Professor of Chemistry, Howard Hughes Medical Institute Early Career Scientist
  • Jeffrey S. Moore, Murchison-Mallory Professor of Chemistry, Howard Hughes Medical Institute Professor
  • Wilfred A. van der Donk, Richard E. Heckert Endowed Chair in Chemistry Howard Hughes Medical Institute Investigator

For more information about the investigator competition please visit the HHMI website.

 
 
 

Carle Cancer Research Update Meeting

Join the discussion at the Carle Cancer Research Update Meeting. This week Dr. King Li, dean and chief medical officer at the Carle Illinois College of Medicine, will present “Molecular Theranostics.” Lunch is not served, but you are welcome to bring your own lunch if you would like.

TOPIC:

"Molecular Theranostics"

SPEAKERS:

Dr. King Li
Dean and Chief Academic Officer
Carle Illinois College of Medicine

DATE:

April 14, 2017
Noon-12:30 p.m. CST

WHERE:

Carle Cancer Center/MBCI-2nd Floor
Houseworth Conference Room

 
 
 

FUNDING ANNOUNCEMENTS

 
 
 
 Mesothelioma Applied Research Foundation Image
 

$100K for Mesothelioma Research

The Meso Foundation (formerly the Mesothelioma Applied Research Foundation) is accepting applications for mesothelioma research grant funding. Scientists at all levels are encouraged to apply. Grants of up to $100,000 over two years will be awarded to qualified investigators for projects related to benchwork, translational, or clinical research that is not presently funded or pending review. Encouraged projects include, but are not limited to, investigations of strategies for early detection or prevention, definition of targetable differences between normal and transformed mesothelium, development of novel strategies for treatment, therapeutic intervention, and determination of clinical/molecular determinants for prognosis. See the Meso Foundation website for complete program guidelines, information about previous grant recipients, and application instructions.

Deadline: August 5, 2017

Complete RFP

 
 
 

IN THE NEWS

 
 
 
 This image of the human brain uses colors and shapes to show neurological differences between two people. The blurred front portion of the brain is associated with complex thought. Credit: Arthur Toga, University of California, Los Angeles
 This image of the human brain uses colors and shapes to show neurological differences between two people. The blurred front portion of the brain is associated with complex thought. Credit: Arthur Toga, University of California, Los Angeles
 

Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment

For decades, cancer survivors have described experiencing problems with memory, attention, and processing information months or even years after treatment. Because so many of these survivors had chemotherapy, this phenomenon has been called "chemobrain" or "chemofog," but researchers say those terms don't always fit the varied impairments experienced by these patients. Why cancer treatment-related cognitive impairment occurs isn't fully understood. But recent research, including the largest study to date of breast cancer survivors to focus on this problem, aims to find the factors that might predict which patients will have cognitive impairment after treatment and to identify what can be done to lessen its impact.

Read the full story here.

 
 
 

Visit our Events Calendar for a complete list of upcoming cancer-related activities and events.